Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Veterinary medicine
Name of medicinal product: Animedazon
Active substances:
Estonian, English, Latin
ATC code: QD06AA02
Dosage form: cutaneous spray, suspension
Strength: 2,45% w/w
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):  (last updated June 30, 2020)
Package information leaflet (PIL): EST  (last updated June 30, 2020)
Labelling:  (last updated July 29, 2016)
Indication: Treatment of superficial traumatic or surgical wounds contaminated with chlortetracycline-sensitive agents. The product can be used as part of a treatment for superficial skin and claw infections, in particular interdigital dermatitis (foot rot and foul in the foot) and digital dermatitis caused by micro-organisms sensitive to chlortetracycline.
Safety features: No
Marketing authorization holder: aniMedica GmbH 
Marketing authorization number: 1913 
Marketing authorization issued on: June 30, 2015 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Mutual recognition 
Assessment report:  (last updated January 11, 2016) 
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1677247  Animedazon  cutaneous spray, suspension  2,45% w/w 211ml 1TK  Prescription      10.05.2016     
1677258  Animedazon  cutaneous spray, suspension  2,45% w/w 211ml 12TK  Prescription      13.12.2022     
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere